Literature DB >> 22541292

Perturbation of dendritic protrusions in intellectual disability.

Josien Levenga1, Rob Willemsen.   

Abstract

Intellectual disability (ID) affects 1-3% of the general population and is defined by an intelligence quotient score under 70 and the presence of two or more adaptive behaviors. Learning and memory involves the change in the transmission efficacy at the synapse (synaptic plasticity). Synaptic plasticity is the ability of the connection, or synapse, between two functional neurons to change in strength. Many molecular mechanisms are involved in the change in synaptic strength, which can result in changes in spine morphology. Spines are specialized dendritic protrusions and their change in morphology is implicated in learning and memory. In several cases of ID, the link between spine abnormalities (abnormal in number, size, and shape) and ID is well described, including nonsyndromic ID and Down, Fragile X, and Rett syndromes. This chapter discusses the underlying molecular mechanisms of this altered spine phenotype.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22541292     DOI: 10.1016/B978-0-444-54299-1.00008-X

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN: 0079-6123            Impact factor:   2.453


  17 in total

1.  Fragile X Syndrome FMRP Co-localizes with Regulatory Targets PSD-95, GABA Receptors, CaMKIIα, and mGluR5 at Fiber Cell Membranes in the Eye Lens.

Authors:  Peter H Frederikse; Anoop Nandanoor; Chinnaswamy Kasinathan
Journal:  Neurochem Res       Date:  2015-08-23       Impact factor: 3.996

2.  MicroRNA-137 regulates a glucocorticoid receptor-dependent signalling network: implications for the etiology of schizophrenia.

Authors:  Astrid Vallès; Gerard J M Martens; Peter De Weerd; Geert Poelmans; Armaz Aschrafi
Journal:  J Psychiatry Neurosci       Date:  2014-09       Impact factor: 6.186

Review 3.  Dendritic structural plasticity and neuropsychiatric disease.

Authors:  Marc P Forrest; Euan Parnell; Peter Penzes
Journal:  Nat Rev Neurosci       Date:  2018-03-16       Impact factor: 34.870

4.  Mutation of the HERC 1 Ubiquitin Ligase Impairs Associative Learning in the Lateral Amygdala.

Authors:  Eva Mª Pérez-Villegas; José V Negrete-Díaz; Mª Elena Porras-García; Rocío Ruiz; Angel M Carrión; Antonio Rodríguez-Moreno; José A Armengol
Journal:  Mol Neurobiol       Date:  2017-01-19       Impact factor: 5.590

5.  Synaptic actin stabilization protein loss in Down syndrome and Alzheimer disease.

Authors:  Julie C Lauterborn; Conor D Cox; See Wing Chan; Peter W Vanderklish; Gary Lynch; Christine M Gall
Journal:  Brain Pathol       Date:  2019-09-08       Impact factor: 6.508

Review 6.  Dendritic spine dysgenesis in autism related disorders.

Authors:  Mary Phillips; Lucas Pozzo-Miller
Journal:  Neurosci Lett       Date:  2015-01-08       Impact factor: 3.046

7.  Short-term treatment with the GABAA receptor antagonist pentylenetetrazole produces a sustained pro-cognitive benefit in a mouse model of Down's syndrome.

Authors:  D Colas; B Chuluun; D Warrier; M Blank; D Z Wetmore; P Buckmaster; C C Garner; H C Heller
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

8.  Identification of Mob2, a novel regulator of larval neuromuscular junction morphology, in natural populations of Drosophila melanogaster.

Authors:  Megan Campbell; Barry Ganetzky
Journal:  Genetics       Date:  2013-08-26       Impact factor: 4.562

9.  In vivo synaptic transmission and morphology in mouse models of Tuberous sclerosis, Fragile X syndrome, Neurofibromatosis type 1, and Costello syndrome.

Authors:  Tiantian Wang; Laura de Kok; Rob Willemsen; Ype Elgersma; J Gerard G Borst
Journal:  Front Cell Neurosci       Date:  2015-07-03       Impact factor: 5.505

10.  Postnatal development of layer III pyramidal cells in the primary visual, inferior temporal, and prefrontal cortices of the marmoset.

Authors:  Tomofumi Oga; Hirosato Aoi; Tetsuya Sasaki; Ichiro Fujita; Noritaka Ichinohe
Journal:  Front Neural Circuits       Date:  2013-03-08       Impact factor: 3.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.